30/01/2026
Sanofi Regeneron: Global Innovation Grant – Pathways in Type 2 Inflammation
Description:
(other deadlines by 30.5 and 30.9)
Research in type 2 inflammation and associated diseases, including, but not limited to, atopic dermatitis, bullous pemphigoid, chronic spontaneous urticaria, prurigo nodularis, eosinophilic esophagitis, asthma, chronic obstructive pulmonary disease, chronic rhinosinusitis with nasal polyps or other type 2 immune-mediated diseases that are relevant in clinical practice. We will prioritize research projects with clear potential to significantly advance scientific understanding of type 2 immune-mediated diseases and improve outcomes in patient care or reduce individual disease burden.
Funding: up to $500K
Fields :
-
Life Sciences
Source :
Foreign
